JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer

Thumbnail
View/Open
Publication Date
2021-02-15
ICR Author
Gil, Veronica
Author
Paschalis, A
Welti, J
Neeb, AJ
Yuan, W
Figueiredo, I
Pereira, R
Ferreira, A
Riisnaes, R
Rodrigues, DN
Jimenez-Vacas, JM
Kim, S
Uo, T
Di Micco, P
Tumber, A
Islam, MS
Moesser, MA
Abboud, M
Kawamura, A
Gurel, B
Christova, R
Gil, VS
Buroni, L
Crespo, M
Miranda, S
Lambros, MB
Carreira, S
Tunariu, N
Alimonti, A
Al-Lazikani, B
Schofield, CJ
Plymate, SR
Sharp, A
de Bono, JS
Type
Journal Article
Metadata
Show full item record
URL
https://repository.icr.ac.uk/handle/internal/4494
Collections
Licenseref URL
http://www.rioxx.net/licenses/all-rights-reserved
Version
VoR
Version of record
Subject
Science & Technology
Life Sciences & Biomedicine
Oncology
ANDROGEN-RECEPTOR
INCREASED SURVIVAL
GENE
PROTEIN
PROGRESSION
ABIRATERONE
VALIDATION
INHIBITORS
INTERACTS
ONTOLOGY
Research team
Computational Biology and Chemogenomics
Cancer Biomarkers
Prostate Cancer Targeted Therapy Group
Computational Biology and Chemogenomics
Cancer Biomarkers
Prostate Cancer Targeted Therapy Group
Language
eng
Date accepted
2020-12-02
License start date
2021-02-15
2021-02-15
Citation
CANCER RESEARCH, 2021, 81 (4), pp. 1087 - 1100 (14)
Publisher
AMER ASSOC CANCER RESEARCH